Skip to main content
Clinical Trials/JPRN-UMIN000047729
JPRN-UMIN000047729
Completed
未知

A verification study of the reduction effect of triglyceride: a randomized, placebo-controlled, double-blind, parallel-group comparison study - A verification study of the reduction effect of triglyceride

ORTHOMEDICO Inc.0 sites44 target enrollmentDecember 12, 2022

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
ORTHOMEDICO Inc.
Enrollment
44
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 12, 2022
End Date
August 20, 2022
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\. Subjects who are undergoing medical treatment or have a medical history of malignant tumor, heart failure, and myocardial infarction 2\. Subjects who have a pacemaker or an implantable cardioverter defibrillator (ICD) 3\. Subjects who currently undergoing treatment for any of the following chronic disease: cardiac arrhythmia, liver disorder, kidney disorder, cerebrovascular disorder, rheumatism, diabetes mellitus, dyslipidemia, hypertension, or any other chronic diseases 4\. Subjects who take "Foods for Specified Health Uses," "Foods with Functional Claims," or other functional food/beverage in daily use 5\. Subjects who currently taking medications (including herbal medicines) and supplements 6\. Subjects who are allergic to medicines and/or the test food related products 7\. Subjects who are pregnant, lactation, or planning to become pregnant 8\. Subjects who suffer from COVID\-19 9\. Subjects who have been enrolled in other clinical trials within the last 28 days before the agreement to participate in this trial or plan to participate another trial during this trial 10\. Subjects who are judged as ineligible to participate in the study by the physician

Outcomes

Primary Outcomes

Not specified

Similar Trials